<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38542351</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3378</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25063378</ELocationID><Abstract><AbstractText>Viruses provide vital insights into gene expression control. Viral transactivators, with other viral and cellular proteins, regulate expression of self, other viruses, and host genes with profound effects on infected cells, underlying inflammation, control of immune responses, and pathogenesis. The multifunctional Tat proteins of lentiviruses (HIV-1, HIV-2, and SIV) transactivate gene expression by recruiting host proteins and binding to transacting responsive regions (TARs) in viral and host RNAs. SARS-CoV-2 nucleocapsid participates in early viral transcription, recruits similar cellular proteins, and shares intracellular, surface, and extracellular distribution with Tat. SARS-CoV-2 nucleocapsid interacting with the replication-transcription complex might, therefore, transactivate viral and cellular RNAs in the transcription and reactivation of self and other viruses, acute and chronic pathogenesis, immune evasion, and viral evolution. Here, we show, by using primary and secondary structural comparisons, that the leaders of SARS-CoV-2 and other coronaviruses contain TAR-like sequences in stem-loops 2 and 3. The coronaviral nucleocapsid C-terminal domains harbor a region of similarity to TAR-binding regions of lentiviral Tat proteins, and coronaviral nonstructural protein 12 has a cysteine-rich metal binding, dimerization domain, as do lentiviral Tat proteins. Although SARS-CoV-1 nucleocapsid transactivated gene expression in a replicon-based study, further experimental evidence for coronaviral transactivation and its possible implications is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patarca</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5821-1749</Identifier><AffiliationInfo><Affiliation>ACCESS Health International, 384 West Lane, Ridgefield, CT 06877, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Feinstein Institutes for Medical Research, 350 Community Dr, Manhasset, NY 11030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haseltine</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>ACCESS Health International, 384 West Lane, Ridgefield, CT 06877, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Feinstein Institutes for Medical Research, 350 Community Dr, Manhasset, NY 11030, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015696">Gene Products, tat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054322">tat Gene Products, Human Immunodeficiency Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="Y">HIV-1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016325" MajorTopicYN="N">HIV Long Terminal Repeat</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015696" MajorTopicYN="N">Gene Products, tat</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016086" MajorTopicYN="N">Lentivirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054322" MajorTopicYN="N">tat Gene Products, Human Immunodeficiency Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HEMIX</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">RNA-dependent RNA polymerase</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">TAR</Keyword><Keyword MajorTopicYN="N">Tat</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">nucleocapsid</Keyword><Keyword MajorTopicYN="N">pan-coronaviral target</Keyword><Keyword MajorTopicYN="N">transactivation</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38542351</ArticleId><ArticleId IdType="pmc">PMC10970485</ArticleId><ArticleId IdType="doi">10.3390/ijms25063378</ArticleId><ArticleId IdType="pii">ijms25063378</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sodroski J., Patarca R., Rosen C., Wong-Staal F., Haseltine W. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science. 1985;229:74&#x2013;77. doi: 10.1126/science.2990041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2990041</ArticleId><ArticleId IdType="pubmed">2990041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodroski J., Rosen C., Wong-Staal F., Salahuddin S.Z., Popovic M., Arya S., Gallo R.C., Haseltine W.A. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science. 1985;227:171&#x2013;173. doi: 10.1126/science.2981427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2981427</ArticleId><ArticleId IdType="pubmed">2981427</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayton A.I., Sodroski J.G., Rosen C.A., Goh W.C., Haseltine W.A. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell. 1986;44:941&#x2013;947. doi: 10.1016/0092-8674(86)90017-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90017-6</ArticleId><ArticleId IdType="pubmed">2420471</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto T., Wong-Staal F. Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system. Cell. 1986;47:29&#x2013;35. doi: 10.1016/0092-8674(86)90363-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90363-6</ArticleId><ArticleId IdType="pubmed">3019564</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto T., Benter T., Josephs S.F., Sadaie M.R., Wong-Staal F. Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. Virology. 1990;177:606&#x2013;614. doi: 10.1016/0042-6822(90)90526-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(90)90526-W</ArticleId><ArticleId IdType="pubmed">2371770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov D., Kwak Y.T., Nee E., Guo J., Garc&#xed;a-Mart&#xed;nez L.F., Gaynor R.B. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J. Mol. Biol. 1999;288:41&#x2013;56. doi: 10.1006/jmbi.1999.2663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.2663</ArticleId><ArticleId IdType="pubmed">10329125</ArticleId></ArticleIdList></Reference><Reference><Citation>Parada C.A., Roeder R.G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 1996;384:375&#x2013;378. doi: 10.1038/384375a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/384375a0</ArticleId><ArticleId IdType="pubmed">8934526</ArticleId></ArticleIdList></Reference><Reference><Citation>He N., Zhou Q. New insights into the control of HIV-1 transcription: When Tat meets the 7SK snRNP and super elongation complex (SEC) J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol. 2011;6:260&#x2013;268. doi: 10.1007/s11481-011-9267-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-011-9267-6</ArticleId><ArticleId IdType="pmc">PMC3087102</ArticleId><ArticleId IdType="pubmed">21360054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieniasz P.D., Grdina T.A., Bogerd H.P., Cullen B.R. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. USA. 1999;96:7791&#x2013;7796. doi: 10.1073/pnas.96.14.7791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.14.7791</ArticleId><ArticleId IdType="pmc">PMC22140</ArticleId><ArticleId IdType="pubmed">10393900</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber M.E., Mayall T.P., Suess E.M., Meisenhelder J., Thompson N.E., Jones K.A. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 2000;20:6958&#x2013;6969. doi: 10.1128/MCB.20.18.6958-6969.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.18.6958-6969.2000</ArticleId><ArticleId IdType="pmc">PMC88771</ArticleId><ArticleId IdType="pubmed">10958691</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter S., Cao H., Rana T.M. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation. Biochemistry. 2002;41:6391&#x2013;6397. doi: 10.1021/bi0159579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0159579</ArticleId><ArticleId IdType="pubmed">12009901</ArticleId></ArticleIdList></Reference><Reference><Citation>Karn J., Stoltzfus C.M. Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb. Perspect. Med. 2012;2:a006916. doi: 10.1101/cshperspect.a006916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006916</ArticleId><ArticleId IdType="pmc">PMC3281586</ArticleId><ArticleId IdType="pubmed">22355797</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamitsu K., Okamoto T. The Tat/P-TEFb protein-protein interaction determining transcriptional activation of HIV. Curr. Pharm. Des. 2017;23:4091&#x2013;4097. doi: 10.2174/1381612823666170710164148.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170710164148</ArticleId><ArticleId IdType="pubmed">28699519</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamitsu K., Fujinaga K., Okamoto T. HIV tat/P-TEFb interaction: A potential target for novel anti-HIV therapies. Molecules. 2018;23:933. doi: 10.3390/molecules23040933.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23040933</ArticleId><ArticleId IdType="pmc">PMC6017356</ArticleId><ArticleId IdType="pubmed">29673219</ArticleId></ArticleIdList></Reference><Reference><Citation>Chameettachal A., Mustafa F., Rizvi T.A. Understanding Retroviral Life Cycle and its Genomic RNA Packaging. J. Mol. Biol. 2023;435:167924. doi: 10.1016/j.jmb.2022.167924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2022.167924</ArticleId><ArticleId IdType="pubmed">36535429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzmina A., Krasnopolsky S., Taube R. Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb. Transcription. 2017;8:133&#x2013;149. doi: 10.1080/21541264.2017.1295831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541264.2017.1295831</ArticleId><ArticleId IdType="pmc">PMC5501376</ArticleId><ArticleId IdType="pubmed">28340332</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya S.K., Gallo R.C., Hahn B.H., Shaw G.M., Popovic M., Salahuddin S.Z., Wong-Staal F. Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. Science. 1984;225:927&#x2013;930. doi: 10.1126/science.6089333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6089333</ArticleId><ArticleId IdType="pubmed">6089333</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen C.A., Sodroski J.G., Haseltine W.A. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell. 1985;41:813&#x2013;823. doi: 10.1016/S0092-8674(85)80062-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(85)80062-3</ArticleId><ArticleId IdType="pubmed">2988790</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhout B., Jeang K.T. Trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J. Virol. 1989;63:5501&#x2013;5504. doi: 10.1128/jvi.63.12.5501-5504.1989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.63.12.5501-5504.1989</ArticleId><ArticleId IdType="pmc">PMC251225</ArticleId><ArticleId IdType="pubmed">2479775</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingwall C., Ernberg I., Gait M.J., Green S.M., Heaphy S., Karn J., Lowe A.D., Singh M., Skinner M.A., Valerio R. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA. 1989;86:6925&#x2013;6929. doi: 10.1073/pnas.86.18.6925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.18.6925</ArticleId><ArticleId IdType="pmc">PMC297963</ArticleId><ArticleId IdType="pubmed">2476805</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks K.M., Ampe C., Schultz S.C., Steitz T.A., Crothers D.M. Fragments of the HIV-1 Tat protein specifically biand TAR RNA. Science. 1990;249:1281&#x2013;1285. doi: 10.1126/science.2205002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2205002</ArticleId><ArticleId IdType="pubmed">2205002</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks K.M., Crothers D.M. RNA recognition by Tat-derived peptides: Interaction in the major groove? Cell. 1991;66:577&#x2013;588. doi: 10.1016/0092-8674(81)90020-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(81)90020-9</ArticleId><ArticleId IdType="pubmed">1907891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner-Smith M., Roy S., Barnett R., Reid L.S., Kuperman R., Delling U., Sonenberg N. Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein. J. Virol. 1991;65:5196&#x2013;5202. doi: 10.1128/jvi.65.10.5196-5202.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.65.10.5196-5202.1991</ArticleId><ArticleId IdType="pmc">PMC248997</ArticleId><ArticleId IdType="pubmed">1895380</ArticleId></ArticleIdList></Reference><Reference><Citation>Karn J. Tackling Tat. J. Mol. Biol. 1999;293:235&#x2013;254. doi: 10.1006/jmbi.1999.3060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.3060</ArticleId><ArticleId IdType="pubmed">10550206</ArticleId></ArticleIdList></Reference><Reference><Citation>Levintov L., Vashisth H. Structural and computational studies of HIV-1 RNA. RNA Biol. 2024;21:1&#x2013;32. doi: 10.1080/15476286.2023.2289709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2023.2289709</ArticleId><ArticleId IdType="pmc">PMC10730233</ArticleId><ArticleId IdType="pubmed">38100535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao S.Y., Calman A.F., Luciw P.A., Peterlin B.M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature. 1987;330:489&#x2013;493. doi: 10.1038/330489a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/330489a0</ArticleId><ArticleId IdType="pubmed">2825027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhim H., Rice A.P. TAR RNA binding properties and relative transactivation activities of human immunodeficiency virus type 1 and 2 Tat proteins. J. Virol. 1993;67:1110&#x2013;1121. doi: 10.1128/jvi.67.2.1110-1121.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.2.1110-1121.1993</ArticleId><ArticleId IdType="pmc">PMC237470</ArticleId><ArticleId IdType="pubmed">8419640</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen B.R. RNA-sequence-mediated gene regulation in HIV-1. Infect. Agents Dis. 1994;3:68&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">7812657</ArticleId></ArticleIdList></Reference><Reference><Citation>Roebuck K.A., Saifuddin M. Regulation of HIV-1 transcription. Gene Expr. 1999;8:67&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6157391</ArticleId><ArticleId IdType="pubmed">10551796</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler M., Mathews M.B. Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts. J. Virol. 1992;66:4488&#x2013;4496. doi: 10.1128/jvi.66.7.4488-4496.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.66.7.4488-4496.1992</ArticleId><ArticleId IdType="pmc">PMC241258</ArticleId><ArticleId IdType="pubmed">1602555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnasabapathy R., Sheldon M., Johal L., Hernandez N. The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev. 1990;4:2061&#x2013;2074. doi: 10.1101/gad.4.12a.2061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.4.12a.2061</ArticleId><ArticleId IdType="pubmed">2269426</ArticleId></ArticleIdList></Reference><Reference><Citation>Toohey M.G., Jones K.A. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes Dev. 1989;3:265&#x2013;282. doi: 10.1101/gad.3.3.265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.3.3.265</ArticleId><ArticleId IdType="pubmed">2542124</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark E., Nava B., Caputi M. Tat is a multifunctional viral protein that modulates cellular gene expression and functions. Oncotarget. 2017;8:27569&#x2013;27581. doi: 10.18632/oncotarget.15174.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.15174</ArticleId><ArticleId IdType="pmc">PMC5432358</ArticleId><ArticleId IdType="pubmed">28187438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada T., Takagi T., Yamaguchi Y., Ferdous A., Imai T., Hirose S., Sugimoto S., Yano K., Hartzog G.A., Winston F., et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 1998;12:343&#x2013;356. doi: 10.1101/gad.12.3.343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.12.3.343</ArticleId><ArticleId IdType="pmc">PMC316480</ArticleId><ArticleId IdType="pubmed">9450929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada T., Orphanides G., Hasegawa J., Kim D.K., Shima D., Yamaguchi Y., Fukuda A., Hisatake K., Oh S., Reinberg D., et al. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH. Mol. Cell. 2000;5:1067&#x2013;1072. doi: 10.1016/S1097-2765(00)80272-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)80272-5</ArticleId><ArticleId IdType="pubmed">10912001</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Kasten M., De Falco G., Micheli P., Khalili K., Giordano A. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression. J. Cell. Biochem. 1999;75:357&#x2013;368. doi: 10.1002/(SICI)1097-4644(19991201)75:3&lt;357::AID-JCB1&gt;3.0.CO;2-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4644(19991201)75:3&lt;357::AID-JCB1&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">10536359</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcello A., Zopp&#xe9; M., Giacca M. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. IUBMB Life. 2001;51:175&#x2013;181. doi: 10.1080/152165401753544241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/152165401753544241</ArticleId><ArticleId IdType="pubmed">11547919</ArticleId></ArticleIdList></Reference><Reference><Citation>Isel C., Karn J. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J. Mol. Biol. 1999;290:929&#x2013;941. doi: 10.1006/jmbi.1999.2933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.2933</ArticleId><ArticleId IdType="pubmed">10438593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeang K.T., Xiao H., Rich E.A. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 1999;274:28837&#x2013;28840. doi: 10.1074/jbc.274.41.28837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.41.28837</ArticleId><ArticleId IdType="pubmed">10506122</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Halanski M.A., Radonovich M.F., Kashanchi F., Peng J., Price D.H., Brady J.N. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 2000;20:5077&#x2013;5086. doi: 10.1128/MCB.20.14.5077-5086.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.14.5077-5086.2000</ArticleId><ArticleId IdType="pmc">PMC85957</ArticleId><ArticleId IdType="pubmed">10866664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.K., Bourgeois C.F., Isel C., Churcher M.J., Karn J. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol. Cell. Biol. 2002;22:4622&#x2013;4637. doi: 10.1128/MCB.22.13.4622-4637.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.13.4622-4637.2002</ArticleId><ArticleId IdType="pmc">PMC133925</ArticleId><ArticleId IdType="pubmed">12052871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamasaki T., Okamoto M., Baba M. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction. Antimicrob. Agents Chemother. 2013;57:1323&#x2013;1331. doi: 10.1128/AAC.01711-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01711-12</ArticleId><ArticleId IdType="pmc">PMC3591921</ArticleId><ArticleId IdType="pubmed">23274668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Yu D., Hansen A.S., Ganguly S., Liu R., Heckert A., Darzacq X., Zhou Q. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II. Nature. 2018;558:318&#x2013;323. doi: 10.1038/s41586-018-0174-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0174-3</ArticleId><ArticleId IdType="pmc">PMC6475116</ArticleId><ArticleId IdType="pubmed">29849146</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y., Tang Y.D., Zheng C. When cyclin-dependent kinases meet viral infections, including SARS-CoV-2. J. Med. Virol. 2022;94:2962&#x2013;2968. doi: 10.1002/jmv.27719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27719</ArticleId><ArticleId IdType="pmc">PMC9088476</ArticleId><ArticleId IdType="pubmed">35288942</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinaga K., Huang F., Peterlin B.M. P-TEFb: The master regulator of transcription elongation. Mol. Cell. 2023;83:393&#x2013;403. doi: 10.1016/j.molcel.2022.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.12.006</ArticleId><ArticleId IdType="pmc">PMC9898187</ArticleId><ArticleId IdType="pubmed">36599353</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinaga K., Irwin D., Huang Y., Taube R., Kurosu T., Peterlin B.M. Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol. 2004;24:787&#x2013;795. doi: 10.1128/MCB.24.2.787-795.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.2.787-795.2004</ArticleId><ArticleId IdType="pmc">PMC343783</ArticleId><ArticleId IdType="pubmed">14701750</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S., Schroeder S., Ott M. CYCLINg through transcription: Post-translational modifications of P-TEFb regulate transcription elongation. Cell Cycle. 2010;9:1697&#x2013;1705. doi: 10.4161/cc.9.9.11346.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.9.9.11346</ArticleId><ArticleId IdType="pmc">PMC2956491</ArticleId><ArticleId IdType="pubmed">20436276</ArticleId></ArticleIdList></Reference><Reference><Citation>Egloff S. CDK9 keeps RNA polymerase II on track. Cell. Mol. Life Sci. CMLS. 2021;78:5543&#x2013;5567. doi: 10.1007/s00018-021-03878-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-03878-8</ArticleId><ArticleId IdType="pmc">PMC8257543</ArticleId><ArticleId IdType="pubmed">34146121</ArticleId></ArticleIdList></Reference><Reference><Citation>Yik J.H., Chen R., Pezda A.C., Samford C.S., Zhou Q. A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb. Mol. Cell. Biol. 2004;24:5094&#x2013;5105. doi: 10.1128/MCB.24.12.5094-5105.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.12.5094-5105.2004</ArticleId><ArticleId IdType="pmc">PMC419863</ArticleId><ArticleId IdType="pubmed">15169877</ArticleId></ArticleIdList></Reference><Reference><Citation>Muniz L., Egloff S., Ughy B., J&#xe1;dy B.E., Kiss T. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat. PLoS Pathog. 2010;6:e1001152. doi: 10.1371/journal.ppat.1001152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001152</ArticleId><ArticleId IdType="pmc">PMC2954905</ArticleId><ArticleId IdType="pubmed">20976203</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobhian B., Laguette N., Yatim A., Nakamura M., Levy Y., Kiernan R., Benkirane M. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol. Cell. 2010;38:439&#x2013;451. doi: 10.1016/j.molcel.2010.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.04.012</ArticleId><ArticleId IdType="pmc">PMC3595998</ArticleId><ArticleId IdType="pubmed">20471949</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Yik J.H., Chen R., He N., Jang M.K., Ozato K., Zhou Q. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell. 2005;19:535&#x2013;545. doi: 10.1016/j.molcel.2005.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.06.029</ArticleId><ArticleId IdType="pubmed">16109377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekhai S., Jeang K.T. Transcriptional and post-transcriptional regulation of HIV-1 gene expression: Role of cellular factors for Tat and Rev. Future Microbiol. 2006;1:417&#x2013;426. doi: 10.2217/17460913.1.4.417.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/17460913.1.4.417</ArticleId><ArticleId IdType="pubmed">17661632</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardabasso C., Manganaro L., Lusic M., Marcello A., Giacca M. The histone chaperone protein nucleosome assembly protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription. Retrovirology. 2008;5:8. doi: 10.1186/1742-4690-5-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-5-8</ArticleId><ArticleId IdType="pmc">PMC2266780</ArticleId><ArticleId IdType="pubmed">18226242</ArticleId></ArticleIdList></Reference><Reference><Citation>Easley R., Van Duyne R., Coley W., Guendel I., Dadgar S., Kehn-Hall K., Kashanchi F. Chromatin dynamics associated with HIV-1 Tat-activated transcription. Biochim. Biophys. Acta. 2010;1799:275&#x2013;285. doi: 10.1016/j.bbagrm.2009.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2009.08.008</ArticleId><ArticleId IdType="pmc">PMC2838975</ArticleId><ArticleId IdType="pubmed">19716452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry K.J., Reddy H.R., Pandita R., Totpal K., Aggarwal B.B. HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. J. Biol. Chem. 1990;265:20091&#x2013;20093. doi: 10.1016/S0021-9258(17)30473-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)30473-8</ArticleId><ArticleId IdType="pubmed">2243081</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonaguro L., Buonaguro F.M., Giraldo G., Ensoli B. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 1994;68:2677&#x2013;2682. doi: 10.1128/jvi.68.4.2677-2682.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.4.2677-2682.1994</ArticleId><ArticleId IdType="pmc">PMC236745</ArticleId><ArticleId IdType="pubmed">8139045</ArticleId></ArticleIdList></Reference><Reference><Citation>Brother M.B., Chang H.K., Lisziewicz J., Su D., Murty L.C., Ensoli B. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys. Virology. 1996;222:252&#x2013;256. doi: 10.1006/viro.1996.0416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0416</ArticleId><ArticleId IdType="pubmed">8806505</ArticleId></ArticleIdList></Reference><Reference><Citation>Scala G., Ruocco M.R., Ambrosino C., Mallardo M., Giordano V., Baldassarre F., Dragonetti E., Quinto I., Venuta S. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 1994;179:961&#x2013;971. doi: 10.1084/jem.179.3.961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.179.3.961</ArticleId><ArticleId IdType="pmc">PMC2191426</ArticleId><ArticleId IdType="pubmed">8113688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino C., Ruocco M.R., Chen X., Mallardo M., Baudi F., Trematerra S., Quinto I., Venuta S., Scala G. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors. J. Biol. Chem. 1997;272:14883&#x2013;14892. doi: 10.1074/jbc.272.23.14883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.23.14883</ArticleId><ArticleId IdType="pubmed">9169458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott M., Lovett J.L., Mueller L., Verdin E. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J. Immunol. 1998;160:2872&#x2013;2880. doi: 10.4049/jimmunol.160.6.2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.160.6.2872</ArticleId><ArticleId IdType="pubmed">9510190</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohn-Wippert K., Tevonian E.N., Megaridis M.R., Dar R.D. Similarity in viral and host promoters couples viral reactivation with host cell migration. Nat. Commun. 2017;8:15006. doi: 10.1038/ncomms15006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15006</ArticleId><ArticleId IdType="pmc">PMC5418578</ArticleId><ArticleId IdType="pubmed">28462923</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S.P., Garzino-Demo A. The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: Role of SP-1, AP-1, and NF-kappaB consensus sites. J. Virol. 2000;74:1632&#x2013;1640. doi: 10.1128/JVI.74.4.1632-1640.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.4.1632-1640.2000</ArticleId><ArticleId IdType="pmc">PMC111637</ArticleId><ArticleId IdType="pubmed">10644332</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacca A., Farina M., Maroder M., Alesse E., Screpanti I., Frati L., Gulino A. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif. Biochem. Biophys. Res. Commun. 1994;205:467&#x2013;474. doi: 10.1006/bbrc.1994.2689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1994.2689</ArticleId><ArticleId IdType="pubmed">7999066</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez E., Punz&#xf3;n C., Gonz&#xe1;lez M., Fresno M. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter. J. Immunol. 2001;166:4560&#x2013;4569. doi: 10.4049/jimmunol.166.7.4560.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.7.4560</ArticleId><ArticleId IdType="pubmed">11254713</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasopoulou S., Georgakopoulos T., Mouzaki A. HIV-1 Transcriptional Activator Tat Inhibits IL2 Expression by Preventing the Presence of Pol II on the IL2 Promoter. Biomolecules. 2023;13:881. doi: 10.3390/biom13060881.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13060881</ArticleId><ArticleId IdType="pmc">PMC10296241</ArticleId><ArticleId IdType="pubmed">37371461</ArticleId></ArticleIdList></Reference><Reference><Citation>Patarca R., Heath C., Goldenberg G.J., Rosen C.A., Sodroski J.G., Haseltine W.A., Hansen U.M. Transcription directed by the HIV long terminal repeat in vitro. AIDS Res. Hum. Retroviruses. 1987;3:41&#x2013;55. doi: 10.1089/aid.1987.3.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.1987.3.41</ArticleId><ArticleId IdType="pubmed">3040054</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Pomerantz R.J., Raj G.V., Kashanchi F., Brady J.N., Amini S., Khalili K. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. J. Virol. 1994;68:3971&#x2013;3981. doi: 10.1128/jvi.68.6.3971-3981.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.6.3971-3981.1994</ArticleId><ArticleId IdType="pmc">PMC236903</ArticleId><ArticleId IdType="pubmed">8189531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Morris G.F., Lockyer J.M., Lu M., Wang Z., Morris C.B. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Virology. 1997;235:48&#x2013;64. doi: 10.1006/viro.1997.8672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1997.8672</ArticleId><ArticleId IdType="pubmed">9300036</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer K., Mitra A., Mitra D. Identification of 5&#x2032; upstream sequence involved in HSPBP1 gene transcription and its downregulation during HIV-1 infection. Virus Res. 2023;324:199034. doi: 10.1016/j.virusres.2022.199034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2022.199034</ArticleId><ArticleId IdType="pmc">PMC10194149</ArticleId><ArticleId IdType="pubmed">36581045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary P., Khan S.Z., Rawat P., Augustine T., Raynes D.A., Guerriero V., Mitra D. HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-&#x3ba;B mediated activation of viral gene expression. Nucleic Acids Res. 2016;44:1613&#x2013;1629. doi: 10.1093/nar/gkv1151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1151</ArticleId><ArticleId IdType="pmc">PMC4770212</ArticleId><ArticleId IdType="pubmed">26538602</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Vega L., S&#xe1;nchez-Duffhues G., Fresno M., Schmitz M.L., Mu&#xf1;oz E., Calzado M.A. The 73 kDa subunit of the CPSF complex binds to the HIV-1 LTR promoter and functions as a negative regulatory factor that is inhibited by the HIV-1 Tat protein. J. Mol. Biol. 2007;372:317&#x2013;330. doi: 10.1016/j.jmb.2007.06.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.06.075</ArticleId><ArticleId IdType="pubmed">17669424</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhoef K., Bauer M., Meyerhans A., Berkhout B. On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation. AIDS Res. Hum. Retroviruses. 1998;14:1553&#x2013;1559. doi: 10.1089/aid.1998.14.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.1998.14.1553</ArticleId><ArticleId IdType="pubmed">9840288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cafaro A., Barillari G., Moretti S., Palladino C., Tripiciano A., Falchi M., Picconi O., Pavone Cossut M.R., Campagna M., Arancio A., et al. HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication. Int. J. Mol. Sci. 2020;22:317. doi: 10.3390/ijms22010317.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010317</ArticleId><ArticleId IdType="pmc">PMC7796023</ArticleId><ArticleId IdType="pubmed">33396807</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao K., Niu F., Hu G., Guo M.L., Sil S., Buch S. HIV Tat-mediated induction of autophagy regulates the disruption of ZO-1 in brain endothelial cells. Tissue Barriers. 2020;8:1748983. doi: 10.1080/21688370.2020.1748983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21688370.2020.1748983</ArticleId><ArticleId IdType="pmc">PMC7549738</ArticleId><ArticleId IdType="pubmed">32299282</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins M.V., Joseph S.B., Dittmer D.P., Mackman N. Cardiovascular Disease and Thrombosis in HIV Infection. Arterioscler. Thromb. Vasc. Biol. 2023;43:175&#x2013;191. doi: 10.1161/ATVBAHA.122.318232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.122.318232</ArticleId><ArticleId IdType="pmc">PMC10165851</ArticleId><ArticleId IdType="pubmed">36453273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hernandez M.J., Swanson M.D., Contreras-Galindo R., Cookinham S., King S.R., Noel R.J., Jr., Kaplan M.H., Markovitz D.M. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J. Virol. 2012;86:7790&#x2013;7805. doi: 10.1128/JVI.07215-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.07215-11</ArticleId><ArticleId IdType="pmc">PMC3421662</ArticleId><ArticleId IdType="pubmed">22593154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hernandez M.J., Cavalcoli J.D., Sartor M.A., Contreras-Galindo R., Meng F., Dai M., Dube D., Saha A.K., Gitlin S.D., Omenn G.S., et al. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. J. Virol. 2014;88:8924&#x2013;8935. doi: 10.1128/JVI.00556-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00556-14</ArticleId><ArticleId IdType="pmc">PMC4136263</ArticleId><ArticleId IdType="pubmed">24872592</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;mer C. Viruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases. Front. Neurosci. 2021;15:648629. doi: 10.3389/fnins.2021.648629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.648629</ArticleId><ArticleId IdType="pmc">PMC7994506</ArticleId><ArticleId IdType="pubmed">33776642</ArticleId></ArticleIdList></Reference><Reference><Citation>Dopkins N., Nixon D.F. Activation of human endogenous retroviruses and its physiological consequences. Nat. Rev. Mol. Cell Biol. 2024;25:212&#x2013;222. doi: 10.1038/s41580-023-00674-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-023-00674-z</ArticleId><ArticleId IdType="pubmed">37872387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury M., Taylor J.P., Chang C.F., Rappaport J., Khalili K. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J. Virol. 1992;66:7355&#x2013;7361. doi: 10.1128/jvi.66.12.7355-7361.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.66.12.7355-7361.1992</ArticleId><ArticleId IdType="pmc">PMC240440</ArticleId><ArticleId IdType="pubmed">1331525</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya S.K., Gallo R.C. Human immunodeficiency virus type 2 long terminal repeat: Analysis of regulatory elements. Proc. Natl. Acad. Sci. USA. 1988;85:9753&#x2013;9757. doi: 10.1073/pnas.85.24.9753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.24.9753</ArticleId><ArticleId IdType="pmc">PMC282859</ArticleId><ArticleId IdType="pubmed">2849115</ArticleId></ArticleIdList></Reference><Reference><Citation>Viglianti G.A., Mullins J.I. Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1. J. Virol. 1988;62:4523&#x2013;4532. doi: 10.1128/jvi.62.12.4523-4532.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.62.12.4523-4532.1988</ArticleId><ArticleId IdType="pmc">PMC253562</ArticleId><ArticleId IdType="pubmed">2846868</ArticleId></ArticleIdList></Reference><Reference><Citation>Haseltine W.A., Sodroski J., Patarca R., Briggs D., Perkins D., Wong-Staal F. Structure of 3&#x2032; terminal region of type II human T lymphotropic virus: Evidence for new coding region. Science. 1984;225:419&#x2013;421. doi: 10.1126/science.6330894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6330894</ArticleId><ArticleId IdType="pubmed">6330894</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodroski J., Trus M., Perkins D., Patarca R., Wong-Staal F., Gelmann E., Gallo R., Haseltine W.A. Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus. Proc. Natl. Acad. Sci. USA. 1984;81:4617&#x2013;4621. doi: 10.1073/pnas.81.15.4617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.81.15.4617</ArticleId><ArticleId IdType="pmc">PMC391541</ArticleId><ArticleId IdType="pubmed">6087335</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevins J.R., Raychaudhuri P., Yee A.S., Rooney R.J., Kovesdi I., Reichel R. Transactivation by the adenovirus E1A gene. Biochem. Cell Biol. 1988;66:578&#x2013;583. doi: 10.1139/o88-068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/o88-068</ArticleId><ArticleId IdType="pubmed">3048331</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady J., Bolen J.B., Radonovich M., Salzman N., Khoury G. Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen. Proc. Natl. Acad. Sci. USA. 1984;81:2040&#x2013;2044. doi: 10.1073/pnas.81.7.2040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.81.7.2040</ArticleId><ArticleId IdType="pmc">PMC345432</ArticleId><ArticleId IdType="pubmed">6201850</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz J.J., Dodon M.D., Schaerer-Uthurralt N., Simonin D., Kindbeiter K., Gazzolo L., Madjar J.J. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein. Nature. 1996;379:273&#x2013;277. doi: 10.1038/379273a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/379273a0</ArticleId><ArticleId IdType="pubmed">8538795</ArticleId></ArticleIdList></Reference><Reference><Citation>Scala G., Quinto I., Ruocco M.R., Mallardo M., Ambrosino C., Squitieri B., Tassone P., Venuta S. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 1993;67:2853&#x2013;2861. doi: 10.1128/jvi.67.5.2853-2861.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.5.2853-2861.1993</ArticleId><ArticleId IdType="pmc">PMC237610</ArticleId><ArticleId IdType="pubmed">8386279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.C., Kuo C.W., Wang W.H., Chang T.H., Chang P.J., Chang L.K., Liu S.T. Transcriptional activation of Epstein-Barr virus BRLF1 by USF1 and Rta. J. Gen. Virol. 2015;96:2855&#x2013;2866. doi: 10.1099/jgv.0.000230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000230</ArticleId><ArticleId IdType="pubmed">26297580</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J., Peng X., Gao Y., Li Z., Lu X., Chen Y., Ishaq M., Liu D., Dediego M.L., Enjuanes L., et al. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication. PLoS ONE. 2008;3:e3299. doi: 10.1371/journal.pone.0003299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003299</ArticleId><ArticleId IdType="pmc">PMC2553179</ArticleId><ArticleId IdType="pubmed">18827877</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S., Delling U., Chen C.H., Rosen C.A., Sonenberg N. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev. 1990;4:1365&#x2013;1373. doi: 10.1101/gad.4.8.1365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.4.8.1365</ArticleId><ArticleId IdType="pubmed">2227414</ArticleId></ArticleIdList></Reference><Reference><Citation>Delling U., Reid L.S., Barnett R.W., Ma M.Y., Climie S., Sumner-Smith M., Sonenberg N. Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: Model for TAR RNA tertiary structure. J. Virol. 1992;66:3018&#x2013;3025. doi: 10.1128/jvi.66.5.3018-3025.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.66.5.3018-3025.1992</ArticleId><ArticleId IdType="pmc">PMC241061</ArticleId><ArticleId IdType="pubmed">1560535</ArticleId></ArticleIdList></Reference><Reference><Citation>Churcher M.J., Lamont C., Hamy F., Dingwall C., Green S.M., Lowe A.D., Butler J.G., Gait M.J., Karn J. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J. Mol. Biol. 1993;230:90&#x2013;110. doi: 10.1006/jmbi.1993.1128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1993.1128</ArticleId><ArticleId IdType="pubmed">8450553</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker B., Muckenthaler M., Vives E., Blanchard A., Braddock M., Nacken W., Kingsman A.J., Kingsman S.M. Identification of a novel HIV-1 TAR RNA bulge binding protein. Nucleic Acids Res. 1994;22:3365&#x2013;3372. doi: 10.1093/nar/22.16.3365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/22.16.3365</ArticleId><ArticleId IdType="pmc">PMC523730</ArticleId><ArticleId IdType="pubmed">8078772</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboul-ela F., Karn J., Varani G. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 1995;253:313&#x2013;332. doi: 10.1006/jmbi.1995.0555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1995.0555</ArticleId><ArticleId IdType="pubmed">7563092</ArticleId></ArticleIdList></Reference><Reference><Citation>Naryshkin N.A., Gait M.J., Ivanovskaya M.G. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat. Biochem. Biokhimiia. 1998;63:489&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">9632883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalonde M.S., Lobritz M.A., Ratcliff A., Chamanian M., Athanassiou Z., Tyagi M., Wong J., Robinson J.A., Karn J., Varani G., et al. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. PLoS Pathog. 2011;7:e1002038. doi: 10.1371/journal.ppat.1002038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002038</ArticleId><ArticleId IdType="pmc">PMC3098202</ArticleId><ArticleId IdType="pubmed">21625572</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavali S.S., Bonn-Breach R., Wedekind J.E. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery. J. Biol. Chem. 2019;294:9326&#x2013;9341. doi: 10.1074/jbc.REV119.006860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.REV119.006860</ArticleId><ArticleId IdType="pmc">PMC6579462</ArticleId><ArticleId IdType="pubmed">31080171</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Yan W., Hall A.B., Jiang X. Characterizing Transcriptional Regulatory Sequences in Coronaviruses and Their Role in Recombination. Mol. Biol. Evol. 2021;38:1241&#x2013;1248. doi: 10.1093/molbev/msaa281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msaa281</ArticleId><ArticleId IdType="pmc">PMC7665640</ArticleId><ArticleId IdType="pubmed">33146390</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhout B. Structural features in TAR RNA of human and simian immunodeficiency viruses: A phylogenetic analysis. Nucleic Acids Res. 1992;20:27&#x2013;31. doi: 10.1093/nar/20.1.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/20.1.27</ArticleId><ArticleId IdType="pmc">PMC310321</ArticleId><ArticleId IdType="pubmed">1738599</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhout B., Gatignol A., Silver J., Jeang K.T. Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure. Nucleic Acids Res. 1990;18:1839&#x2013;1846. doi: 10.1093/nar/18.7.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/18.7.1839</ArticleId><ArticleId IdType="pmc">PMC330604</ArticleId><ArticleId IdType="pubmed">2186367</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachulska-Wieczorek K., Purzycka K.J., Adamiak R.W. New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5&#x2032; end of the HIV-2 leader RNA. Nucleic Acids Res. 2006;34:2984&#x2013;2997. doi: 10.1093/nar/gkl373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl373</ArticleId><ArticleId IdType="pmc">PMC1474061</ArticleId><ArticleId IdType="pubmed">16738137</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya S.K., Guo C., Josephs S.F., Wong-Staal F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III) Science. 1985;229:69&#x2013;73. doi: 10.1126/science.2990040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2990040</ArticleId><ArticleId IdType="pubmed">2990040</ArticleId></ArticleIdList></Reference><Reference><Citation>Laspia M.F., Rice A.P., Mathews M.B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 1989;59:283&#x2013;292. doi: 10.1016/0092-8674(89)90290-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90290-0</ArticleId><ArticleId IdType="pubmed">2553266</ArticleId></ArticleIdList></Reference><Reference><Citation>Siomi H., Shida H.I., Maki M.A., Hatanaka M.A. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 1990;64:1803&#x2013;1807. doi: 10.1128/jvi.64.4.1803-1807.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.4.1803-1807.1990</ArticleId><ArticleId IdType="pmc">PMC249318</ArticleId><ArticleId IdType="pubmed">2108259</ArticleId></ArticleIdList></Reference><Reference><Citation>Calnan B.J., Biancalana S., Hudson D., Frankel A.D. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. Genes Dev. 1991;5:201&#x2013;210. doi: 10.1101/gad.5.2.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.5.2.201</ArticleId><ArticleId IdType="pubmed">1899841</ArticleId></ArticleIdList></Reference><Reference><Citation>Calnan B.J., Tidor B., Biancalana S., Hudson D., Frankel A.D. Arginine-mediated RNA recognition: The arginine fork. Science. 1991;252:1167&#x2013;1171. doi: 10.1126/science.252.5009.1167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.252.5009.1167</ArticleId><ArticleId IdType="pubmed">1709522</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiozzini C., Toschi E. HIV-1 TAT and immune dysregulation in aids pathogenesis: A therapeutic target. Curr. Drug Targets. 2016;17:33&#x2013;45. doi: 10.2174/1389450116666150825110658.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450116666150825110658</ArticleId><ArticleId IdType="pubmed">26302810</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R., Chen L., Buettner J.A., Hudson D., Frankel A.D. RNA recognition by an isolated alpha helix. Cell. 1993;73:1031&#x2013;1040. doi: 10.1016/0092-8674(93)90280-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90280-4</ArticleId><ArticleId IdType="pubmed">7684657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury M.N., Jin H. The RGG motif proteins: Interactions, functions, and regulations. Wiley Interdiscip. Rev. RNA. 2023;14:e1748. doi: 10.1002/wrna.1748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1748</ArticleId><ArticleId IdType="pmc">PMC9718894</ArticleId><ArticleId IdType="pubmed">35661420</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotora P.T., van der Sluis R., Williams M.E. HIV-1 Tat amino acid residues that influence Tat-TAR binding affinity: A scoping review. BMC Infect. Dis. 2023;23:164. doi: 10.1186/s12879-023-08123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08123-0</ArticleId><ArticleId IdType="pmc">PMC10020771</ArticleId><ArticleId IdType="pubmed">36932337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Zeng R., von Brunn A., Lei J. Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein. Mol. Biomed. 2020;1:2. doi: 10.1186/s43556-020-00001-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43556-020-00001-4</ArticleId><ArticleId IdType="pmc">PMC7406681</ArticleId><ArticleId IdType="pubmed">34765991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.Y., Chang C.K., Chang Y.W., Sue S.C., Bai H.I., Riang L., Hsiao C.D., Huang T.H. Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J. Mol. Biol. 2007;368:1075&#x2013;1086. doi: 10.1016/j.jmb.2007.02.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.02.069</ArticleId><ArticleId IdType="pmc">PMC7094638</ArticleId><ArticleId IdType="pubmed">17379242</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q., Yu L., Petros A.M., Gunasekera A., Liu Z., Xu N., Hajduk P., Mack J., Fesik S.W., Olejniczak E.T. Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein. Biochemistry. 2004;43:6059&#x2013;6063. doi: 10.1021/bi036155b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi036155b</ArticleId><ArticleId IdType="pubmed">15147189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinzula L., Basquin J., Bohn S., Beck F., Klumpe S., Pfeifer G., Nagy I., Bracher A., Hartl F.U., Baumeister W. High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the COVID-19 severe acute respiratory syndrome coronavirus 2. Biochem. Biophys. Res. Commun. 2021;538:54&#x2013;62. doi: 10.1016/j.bbrc.2020.09.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.09.131</ArticleId><ArticleId IdType="pmc">PMC7532810</ArticleId><ArticleId IdType="pubmed">33039147</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S., Gurry C., Freitas L., Schultz M.B., Bach G., Diallo A., Akite N., Ho J., Lee R.T., Yeo W., et al. GISAID&#x2019;s Role in Pandemic Response. China CDC Wkly. 2021;3:1049&#x2013;1051. doi: 10.46234/ccdcw2021.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbe S., Buckland-Merrett G. Data, disease and diplomacy: GISAID&#x2019;s innovative contribution to global health. Glob. Chall. 2017;1:33&#x2013;46. doi: 10.1002/gch2.1018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gch2.1018</ArticleId><ArticleId IdType="pmc">PMC6607375</ArticleId><ArticleId IdType="pubmed">31565258</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu Y., McCauley J. GISAID: From vision to reality. EuroSurveillance. 2017;22 doi: 10.2807/1560-7917.ES.2017.22.13.30494.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.13.30494</ArticleId><ArticleId IdType="pmc">PMC5388101</ArticleId><ArticleId IdType="pubmed">28382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Surjit M., Kumar R., Mishra R.N., Reddy M.K., Chow V.T., Lal S.K. The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation. J. Virol. 2005;79:11476&#x2013;11486. doi: 10.1128/JVI.79.17.11476-11486.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.17.11476-11486.2005</ArticleId><ArticleId IdType="pmc">PMC1193639</ArticleId><ArticleId IdType="pubmed">16103198</ArticleId></ArticleIdList></Reference><Reference><Citation>Thandapani P., O&#x2019;Connor T.R., Bailey T.L., Richard S. Defining the RGG/RG motif. Mol. Cell. 2013;50:613&#x2013;623. doi: 10.1016/j.molcel.2013.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.05.021</ArticleId><ArticleId IdType="pubmed">23746349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdilek B.A., Thompson V.F., Ahmed N.S., White C.I., Batey R.T., Schwartz J.C. Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding. Nucleic Acids Res. 2017;45:7984&#x2013;7996. doi: 10.1093/nar/gkx460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx460</ArticleId><ArticleId IdType="pmc">PMC5570134</ArticleId><ArticleId IdType="pubmed">28575444</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zandi R. Biophysical Modeling of SARS-CoV-2 Assembly: Genome Condensation and Budding. Viruses. 2022;14:2089. doi: 10.3390/v14102089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102089</ArticleId><ArticleId IdType="pmc">PMC9611094</ArticleId><ArticleId IdType="pubmed">36298645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu I.M., Oldham M.L., Zhang J., Chen J. Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae. J. Biol. Chem. 2006;281:17134&#x2013;17139. doi: 10.1074/jbc.M602107200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M602107200</ArticleId><ArticleId IdType="pmc">PMC7946579</ArticleId><ArticleId IdType="pubmed">16627473</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauber J., Malim M.H., Cullen B.R. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J. Virol. 1989;63:1181&#x2013;1187. doi: 10.1128/jvi.63.3.1181-1187.1989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.63.3.1181-1187.1989</ArticleId><ArticleId IdType="pmc">PMC247813</ArticleId><ArticleId IdType="pubmed">2536828</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng T.Y., Lee K.R., Tarn W.Y. Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization. FEBS J. 2008;275:4152&#x2013;4163. doi: 10.1111/j.1742-4658.2008.06564.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2008.06564.x</ArticleId><ArticleId IdType="pmc">PMC7164085</ArticleId><ArticleId IdType="pubmed">18631359</ArticleId></ArticleIdList></Reference><Reference><Citation>Adly A.N., Bi M., Carlson C.R., Syed A.M., Ciling A., Doudna J.A., Cheng Y., Morgan D.O. Assembly of SARS-CoV-2 ribonucleosomes by truncated N* variant of the nucleocapsid protein. J. Biol. Chem. 2023;299:105362. doi: 10.1016/j.jbc.2023.105362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.105362</ArticleId><ArticleId IdType="pmc">PMC10665939</ArticleId><ArticleId IdType="pubmed">37863261</ArticleId></ArticleIdList></Reference><Reference><Citation>Stertz S., Reichelt M., Spiegel M., Kuri T., Mart&#xed;nez-Sobrido L., Garc&#xed;a-Sastre A., Weber F., Kochs G. The intracellular sites of early replication and budding of SARS-coronavirus. Virology. 2007;361:304&#x2013;315. doi: 10.1016/j.virol.2006.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.11.027</ArticleId><ArticleId IdType="pmc">PMC7103305</ArticleId><ArticleId IdType="pubmed">17210170</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters P.S., Koetzner C.A., Kerr C.A., Heo Y. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J. Virol. 1994;68:328&#x2013;337. doi: 10.1128/jvi.68.1.328-337.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.1.328-337.1994</ArticleId><ArticleId IdType="pmc">PMC236292</ArticleId><ArticleId IdType="pubmed">8254744</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfa;&#xf1;iga S., Cruz J.L., Sola I., Mateos-G&#xf3;mez P.A., Palacio L., Enjuanes L. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J. Virol. 2010;84:2169&#x2013;2175. doi: 10.1128/JVI.02011-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02011-09</ArticleId><ArticleId IdType="pmc">PMC2812394</ArticleId><ArticleId IdType="pubmed">19955314</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaz&#xe1;n F., Gal&#xe1;n C., Enjuanes L. The nucleoprotein is required for efficient coronavirus genome replication. J. Virol. 2004;78:12683&#x2013;12688. doi: 10.1128/JVI.78.22.12683-12688.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.22.12683-12688.2004</ArticleId><ArticleId IdType="pmc">PMC525053</ArticleId><ArticleId IdType="pubmed">15507657</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia J.A., Harrich D., Pearson L., Mitsuyasu R., Gaynor R.B. Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J. 1988;7:3143&#x2013;3147. doi: 10.1002/j.1460-2075.1988.tb03181.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1988.tb03181.x</ArticleId><ArticleId IdType="pmc">PMC454704</ArticleId><ArticleId IdType="pubmed">3181132</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadaie M.R., Mukhopadhyaya R., Benaissa Z.N., Pavlakis G.N., Wong-Staal F. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication. AIDS Res. Hum. Retroviruses. 1990;6:1257&#x2013;1263. doi: 10.1089/aid.1990.6.1257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.1990.6.1257</ArticleId><ArticleId IdType="pubmed">2078407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuppuswamy M., Subramanian T., Srinivasan A., Chinnadurai G. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 1989;17:3551&#x2013;3561. doi: 10.1093/nar/17.9.3551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/17.9.3551</ArticleId><ArticleId IdType="pmc">PMC317795</ArticleId><ArticleId IdType="pubmed">2542902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruben S., Perkins A., Purcell R., Joung K., Sia R., Burghoff R., Haseltine W.A., Rosen C.A. Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol. 1989;63:1&#x2013;8. doi: 10.1128/jvi.63.1.1-8.1989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.63.1.1-8.1989</ArticleId><ArticleId IdType="pmc">PMC247650</ArticleId><ArticleId IdType="pubmed">2535718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice A.P., Carlotti F. Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins. J. Virol. 1990;64:6018&#x2013;6026. doi: 10.1128/jvi.64.12.6018-6026.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.12.6018-6026.1990</ArticleId><ArticleId IdType="pmc">PMC248775</ArticleId><ArticleId IdType="pubmed">2243385</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankel A.D., Bredt D.S., Pabo C.O. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science. 1988;240:70&#x2013;73. doi: 10.1126/science.2832944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2832944</ArticleId><ArticleId IdType="pubmed">2832944</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankel A.D., Chen L., Cotter R.J., Pabo C.O. Dimerization of the tat protein from human immunodeficiency virus: A cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc. Natl. Acad. Sci. USA. 1988;85:6297&#x2013;6300. doi: 10.1073/pnas.85.17.6297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.17.6297</ArticleId><ArticleId IdType="pmc">PMC281956</ArticleId><ArticleId IdType="pubmed">2842763</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong Y., Ulasli M., Schepers H., Mauthe M., V&#x2032;kovski P., Kriegenburg F., Thiel V., de Haan C.A.M., Reggiori F. Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle. J. Virol. 2020;94:e01925-19. doi: 10.1128/JVI.01925-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01925-19</ArticleId><ArticleId IdType="pmc">PMC6997762</ArticleId><ArticleId IdType="pubmed">31776274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.G., Ritter C., Kummer E. Structural insights into the role of GTPBP10 in the RNA maturation of the mitoribosome. Nat. Commun. 2023;14:7991. doi: 10.1038/s41467-023-43599-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43599-z</ArticleId><ArticleId IdType="pmc">PMC10693566</ArticleId><ArticleId IdType="pubmed">38042949</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S.T.B., Whelan D.R., Rozario A.M. Visualizing DNA damage and repair using single molecule super resolution microscopy. Methods Cell Biol. 2024;182:237&#x2013;245. doi: 10.1016/bs.mcb.2023.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.mcb.2023.02.004</ArticleId><ArticleId IdType="pubmed">38359980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappidi N., Quail T., Doll S., Vogel L.T., Aleksandrov R., Felekyan S., K&#xfc;hnemuth R., Stoynov S., Seidel C.A.M., Brugu&#xe9;s J., et al. PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA ends. Cell. 2024;187:945&#x2013;961.e18. doi: 10.1016/j.cell.2024.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2024.01.015</ArticleId><ArticleId IdType="pubmed">38320550</ArticleId></ArticleIdList></Reference><Reference><Citation>Surjit M., Liu B., Chow V.T., Lal S.K. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J. Biol. Chem. 2006;281:10669&#x2013;10681. doi: 10.1074/jbc.M509233200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M509233200</ArticleId><ArticleId IdType="pmc">PMC7995956</ArticleId><ArticleId IdType="pubmed">16431923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M., Memon D., Meyer B., White K.M., Rezelj V.V., Correa Marrero M., Polacco B.J., Melnyk J.E., Ulferts S., Kaake R.M., et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182:685&#x2013;712. doi: 10.1016/j.cell.2020.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M., Chen Y., Qi S., Shi D., Feng L., Sun D. A Mini-Review on Cell Cycle Regulation of Coronavirus Infection. Front. Vet. Sci. 2020;7:586826. doi: 10.3389/fvets.2020.586826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2020.586826</ArticleId><ArticleId IdType="pmc">PMC7674852</ArticleId><ArticleId IdType="pubmed">33251267</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagliani R., Forni D., Clerici M., Sironi M. Computational Inference of Selection Underlying the Evolution of the Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2. J. Virol. 2020;94:e00411-20. doi: 10.1128/JVI.00411-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00411-20</ArticleId><ArticleId IdType="pmc">PMC7307108</ArticleId><ArticleId IdType="pubmed">32238584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sola I., Almaz&#xe1;n F., Z&#xfa;&#xf1;iga S., Enjuanes L. Continuous and Discontinuous RNA Synthesis in Coronaviruses. Annu. Rev. Virol. 2015;2:265&#x2013;288. doi: 10.1146/annurev-virology-100114-055218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-100114-055218</ArticleId><ArticleId IdType="pmc">PMC6025776</ArticleId><ArticleId IdType="pubmed">26958916</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride R., van Zyl M., Fielding B.C. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 2014;6:2991&#x2013;3018. doi: 10.3390/v6082991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6082991</ArticleId><ArticleId IdType="pmc">PMC4147684</ArticleId><ArticleId IdType="pubmed">25105276</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulabbi E.N., Tweyongyere R., Byarugaba D.K. The history of the emergence and transmission of human coronaviruses. Onderstepoort J. Vet. Res. 2021;88:1872. doi: 10.4102/ojvr.v88i1.1872.</Citation><ArticleIdList><ArticleId IdType="doi">10.4102/ojvr.v88i1.1872</ArticleId><ArticleId IdType="pmc">PMC7876959</ArticleId><ArticleId IdType="pubmed">33567843</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai M.M., Cavanagh D. The molecular biology of coronaviruses. Adv. Virus Res. 1997;48:1&#x2013;100. doi: 10.1016/S0065-3527(08)60286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)60286-9</ArticleId><ArticleId IdType="pmc">PMC7130985</ArticleId><ArticleId IdType="pubmed">9233431</ArticleId></ArticleIdList></Reference><Reference><Citation>Wertheim J.O., Chu D.K., Peiris J.S., Kosakovsky Pond S.L., Poon L.L. A case for the ancient origin of coronaviruses. J. Virol. 2013;87:7039&#x2013;7045. doi: 10.1128/JVI.03273-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03273-12</ArticleId><ArticleId IdType="pmc">PMC3676139</ArticleId><ArticleId IdType="pubmed">23596293</ArticleId></ArticleIdList></Reference><Reference><Citation>Forni D., Cagliani R., Clerici M., Sironi M. Molecular Evolution of Human Coronavirus Genomes. Trends Microbiol. 2017;25:35&#x2013;48. doi: 10.1016/j.tim.2016.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.09.001</ArticleId><ArticleId IdType="pmc">PMC7111218</ArticleId><ArticleId IdType="pubmed">27743750</ArticleId></ArticleIdList></Reference><Reference><Citation>Forero-Mu&#xf1;oz N.R., Muylaert R.L., Seifert S.N., Albery G.F., Becker D.J., Carlson C.J., Poisot T. The coevolutionary mosaic of bat betacoronavirus emergence risk. Virus Evol. 2023:vead079. doi: 10.1093/ve/vead079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vead079</ArticleId><ArticleId IdType="pmc">PMC10868545</ArticleId><ArticleId IdType="pubmed">38361817</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P.C., Lau S.K., Huang Y., Yuen K.Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp. Biol. Med. 2009;234:1117&#x2013;1127. doi: 10.3181/0903-MR-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-MR-94</ArticleId><ArticleId IdType="pubmed">19546349</ArticleId></ArticleIdList></Reference><Reference><Citation>Wille M., Holmes E.C. Wild birds as reservoirs for diverse and abundant gamma- and deltacoronaviruses. FEMS Microbiol. Rev. 2020;44:631&#x2013;644. doi: 10.1093/femsre/fuaa026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuaa026</ArticleId><ArticleId IdType="pmc">PMC7454673</ArticleId><ArticleId IdType="pubmed">32672814</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.C., Olsthoorn R.C. Group-specific structural features of the 5&#x2032;-proximal sequences of coronavirus genomic RNAs. Virology. 2010;401:29&#x2013;41. doi: 10.1016/j.virol.2010.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.02.007</ArticleId><ArticleId IdType="pmc">PMC7111916</ArticleId><ArticleId IdType="pubmed">20202661</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhugiri R., Karl N., Petersen D., Lamkiewicz K., Fricke M., Wend U., Scheuer R., Marz M., Ziebuhr J. Structural and functional conservation of cis-acting RNA elements in coronavirus 5&#x2032;-terminal genome regions. Virology. 2018;517:44&#x2013;55. doi: 10.1016/j.virol.2017.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.11.025</ArticleId><ArticleId IdType="pmc">PMC7112051</ArticleId><ArticleId IdType="pubmed">29223446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Tong X., Xu X., Li X., Lou Z., Rao Z. Structures of the N- and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus. Protein Cell. 2010;1:688&#x2013;697. doi: 10.1007/s13238-010-0079-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0079-x</ArticleId><ArticleId IdType="pmc">PMC4875274</ArticleId><ArticleId IdType="pubmed">21203940</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda M., Chang C.K., Ikeya T., G&#xfc;ntert P., Chang Y.H., Hsu Y.L., Huang T.H., Kainosho M. Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method. J. Mol. Biol. 2008;380:608&#x2013;622. doi: 10.1016/j.jmb.2007.11.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.11.093</ArticleId><ArticleId IdType="pmc">PMC7094413</ArticleId><ArticleId IdType="pubmed">18561946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.K., Sue S.C., Yu T.H., Hsieh C.M., Tsai C.K., Chiang Y.C., Lee S.J., Hsiao H.H., Wu W.J., Chang W.L., et al. Modular organization of SARS coronavirus nucleocapsid protein. J. Biomed. Sci. 2006;13:59&#x2013;72. doi: 10.1007/s11373-005-9035-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-005-9035-9</ArticleId><ArticleId IdType="pmc">PMC7089556</ArticleId><ArticleId IdType="pubmed">16228284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst K.R., Koetzner C.A., Masters P.S. Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein. J. Virol. 2009;83:7221&#x2013;7234. doi: 10.1128/JVI.00440-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00440-09</ArticleId><ArticleId IdType="pmc">PMC2704785</ArticleId><ArticleId IdType="pubmed">19420077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Syed A.M., Khalid M.M., Nguyen A., Ciling A., Wu D., Yau W.M., Srinivasan S., Esposito D., Doudna J.A., et al. Assembly reactions of SARS-CoV-2 nucleocapsid protein with nucleic acid. bioRxiv. 2023 doi: 10.1101/2023.11.22.568361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.11.22.568361</ArticleId></ArticleIdList></Reference><Reference><Citation>Korn M., Dhamotharan K., Jeffries C.M., Schlundt A. The preference signature of the SARS-CoV-2 Nucleocapsid NTD for its 5&#x2019;-genomic RNA elements. Nat. Commun. 2023;14:3331. doi: 10.1038/s41467-023-38882-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38882-y</ArticleId><ArticleId IdType="pmc">PMC10246530</ArticleId><ArticleId IdType="pubmed">37286558</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson C.R., Asfaha J.B., Ghent C.M., Howard C.J., Hartooni N., Safari M., Frankel A.D., Morgan D.O. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions. Mol. Cell. 2020;80:1092&#x2013;1103.e4. doi: 10.1016/j.molcel.2020.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7677695</ArticleId><ArticleId IdType="pubmed">33248025</ArticleId></ArticleIdList></Reference><Reference><Citation>Estelle A.B., Forsythe H.M., Yu Z., Hughes K., Lasher B., Allen P., Reardon P.N., Hendrix D.A., Barbar E.J. RNA structure and multiple weak interactions balance the interplay between RNA binding and phase separation of SARS-CoV-2 nucleocapsid. PNAS Nexus. 2023;2:pgad333. doi: 10.1093/pnasnexus/pgad333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgad333</ArticleId><ArticleId IdType="pmc">PMC10605006</ArticleId><ArticleId IdType="pubmed">37901441</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossoehme N.E., Li L., Keane S.C., Liu P., Dann C.E., III, Leibowitz J.L., Giedroc D.P. Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes. J. Mol. Biol. 2009;394:544&#x2013;557. doi: 10.1016/j.jmb.2009.09.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2009.09.040</ArticleId><ArticleId IdType="pmc">PMC2783395</ArticleId><ArticleId IdType="pubmed">19782089</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson C.R., Adly A.N., Bi M., Howard C.J., Frost A., Cheng Y., Morgan D.O. Reconstitution of the SARS-CoV-2 ribonucleosome provides insights into genomic RNA packaging and regulation by phosphorylation. J. Biol. Chem. 2022;298:102560. doi: 10.1016/j.jbc.2022.102560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102560</ArticleId><ArticleId IdType="pmc">PMC9529352</ArticleId><ArticleId IdType="pubmed">36202211</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Jim&#xe9;nez C., Izquierdo J.M. T-cell intracellular antigens in health and disease. Cell Cycle. 2015;14:2033&#x2013;2043. doi: 10.1080/15384101.2015.1053668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2015.1053668</ArticleId><ArticleId IdType="pmc">PMC4614917</ArticleId><ArticleId IdType="pubmed">26036275</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Leibowitz J.L. The structure and functions of coronavirus genomic 3&#x2032; and 5&#x2032; ends. Virus Res. 2015;206:120&#x2013;133. doi: 10.1016/j.virusres.2015.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.02.025</ArticleId><ArticleId IdType="pmc">PMC4476908</ArticleId><ArticleId IdType="pubmed">25736566</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.C., Sexton N.R., Denison M.R. Thinking Outside the Triangle: Replication Fidelity of the Largest RNA Viruses. Annu. Rev. Virol. 2014;1:111&#x2013;132. doi: 10.1146/annurev-virology-031413-085507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-031413-085507</ArticleId><ArticleId IdType="pubmed">26958717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Lu S., Wang Y., He L., Wang M., Jia R., Chen S., Zhu D., Liu M., Zhao X., et al. Bacterial DNA methyltransferase: A key to the epigenetic world with lessons learned from proteobacteria. Front. Microbiol. 2023;14:1129437. doi: 10.3389/fmicb.2023.1129437.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1129437</ArticleId><ArticleId IdType="pmc">PMC10073500</ArticleId><ArticleId IdType="pubmed">37032876</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer K.A., Hiscox J.A. Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino-terminal region. FEBS Lett. 2006;580:5993&#x2013;5998. doi: 10.1016/j.febslet.2006.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.09.052</ArticleId><ArticleId IdType="pmc">PMC7094245</ArticleId><ArticleId IdType="pubmed">17052713</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso &#xcd;.P., Sanches K., Da Poian A.T., Pinheiro A.S., Almeida F.C.L. Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization. Biophys. J. 2021;120:2814&#x2013;2827. doi: 10.1016/j.bpj.2021.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.06.003</ArticleId><ArticleId IdType="pmc">PMC8239202</ArticleId><ArticleId IdType="pubmed">34197802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q., Ponty Y., Will S., et al. The SARS-CoV-2 subgenome landscape and its novel regulatory features. Mol. Cell. 2021;81:2135&#x2013;2147.e5. doi: 10.1016/j.molcel.2021.02.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.02.036</ArticleId><ArticleId IdType="pmc">PMC7927579</ArticleId><ArticleId IdType="pubmed">33713597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziv O., Gabryelska M.M., Lun A.T.L., Gebert L.F.R., Sheu-Gruttadauria J., Meredith L.W., Liu Z.Y., Kwok C.K., Qin C.F., MacRae I.J., et al. COMRADES determines in vivo RNA structures and interactions. Nat. Methods. 2018;15:785&#x2013;788. doi: 10.1038/s41592-018-0121-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-018-0121-0</ArticleId><ArticleId IdType="pmc">PMC6168409</ArticleId><ArticleId IdType="pubmed">30202058</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Kang H., Liu P., Makkinje N., Williamson S.T., Leibowitz J.L., Giedroc D.P. Structural lability in stem-loop 1 drives a 5&#x2032; UTR-3&#x2032; UTR interaction in coronavirus replication. J. Mol. Biol. 2008;377:790&#x2013;803. doi: 10.1016/j.jmb.2008.01.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2008.01.068</ArticleId><ArticleId IdType="pmc">PMC2652258</ArticleId><ArticleId IdType="pubmed">18289557</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Z., Tidu A., Eriani G., Martin F. Secondary structure of the SARS-CoV-2 5&#x2032;-UTR. RNA Biol. 2021;18:447&#x2013;456. doi: 10.1080/15476286.2020.1814556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1814556</ArticleId><ArticleId IdType="pmc">PMC7544965</ArticleId><ArticleId IdType="pubmed">32965173</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn C.S., Hahn Y.S., Rice C.M., Lee E., Dalgarno L., Strauss E.G., Strauss J.H. Conserved elements in the 3&#x2032; untranslated region of flavivirus RNAs and potential cyclization sequences. J. Mol. Biol. 1987;198:33&#x2013;41. doi: 10.1016/0022-2836(87)90455-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(87)90455-4</ArticleId><ArticleId IdType="pubmed">2828633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo C.Y., Tsai T.L., Lin C.N., Lin C.H., Wu H.Y. Interaction of coronavirus nucleocapsid protein with the 5&#x2032;- and 3&#x2032;-ends of the coronavirus genome is involved in genome circularization and negative-strand RNA synthesis. FEBS J. 2019;286:3222&#x2013;3239. doi: 10.1111/febs.14863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14863</ArticleId><ArticleId IdType="pmc">PMC7164124</ArticleId><ArticleId IdType="pubmed">31034708</ArticleId></ArticleIdList></Reference><Reference><Citation>Goebel S.J., Hsue B., Dombrowski T.F., Masters P.S. Characterization of the RNA components of a putative molecular switch in the 3&#x2032; untranslated region of the murine coronavirus genome. J. Virol. 2004;78:669&#x2013;682. doi: 10.1128/JVI.78.2.669-682.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.2.669-682.2004</ArticleId><ArticleId IdType="pmc">PMC368785</ArticleId><ArticleId IdType="pubmed">14694098</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue X., Yang H., Shen W., Zhao Q., Li J., Yang K., Chen C., Jin Y., Bartlam M., Rao Z. Production of authentic SARS-CoV M(pro) with enhanced activity: Application as a novel tag-cleavage endopeptidase for protein overproduction. J. Mol. Biol. 2007;366:965&#x2013;975. doi: 10.1016/j.jmb.2006.11.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2006.11.073</ArticleId><ArticleId IdType="pmc">PMC7094453</ArticleId><ArticleId IdType="pubmed">17189639</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonassen C.M., Jonassen T.O., Grinde B. A common RNA motif in the 3&#x2032; end of the genomes of astroviruses, avian infectious bronchitis virus and an equine rhinovirus. J. Gen. Virol. 1998;79:715&#x2013;718. doi: 10.1099/0022-1317-79-4-715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-79-4-715</ArticleId><ArticleId IdType="pubmed">9568965</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson M.P., Igel H., Baertsch R., Haussler D., Ares M., Jr., Scott W.G. The structure of a rigorously conserved RNA element within the SARS virus genome. PLoS Biol. 2005;3:e5. doi: 10.1371/journal.pbio.0030005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0030005</ArticleId><ArticleId IdType="pmc">PMC539059</ArticleId><ArticleId IdType="pubmed">15630477</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo J.F., Hogue B.G. Host protein interactions with the 3&#x2032; end of bovine coronavirus RNA and the requirement of the poly(A) tail for coronavirus defective genome replication. J. Virol. 2000;74:5053&#x2013;5065. doi: 10.1128/JVI.74.11.5053-5065.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.11.5053-5065.2000</ArticleId><ArticleId IdType="pmc">PMC110857</ArticleId><ArticleId IdType="pubmed">10799579</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarun S.Z., Jr., Wells S.E., Deardorff J.A., Sachs A.B. Translation initiation factor eIF4G mediates in vitro poly(A) tail-dependent translation. Proc. Natl. Acad. Sci. USA. 1997;94:9046&#x2013;9051. doi: 10.1073/pnas.94.17.9046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.17.9046</ArticleId><ArticleId IdType="pmc">PMC23022</ArticleId><ArticleId IdType="pubmed">9256432</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan T., Arya S., Chan S.H., Qi S., Dai N., Misra A., Park J.G., Oladunni F., Kovalskyy D., Hromas R.A., et al. Structural basis of RNA cap modification by SARS-CoV-2. Nat. Commun. 2020;11:3718. doi: 10.1038/s41467-020-17496-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17496-8</ArticleId><ArticleId IdType="pmc">PMC7381649</ArticleId><ArticleId IdType="pubmed">32709886</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel V., Ivanov K.A., Putics &#xc1;., Hertzig T., Schelle B., Bayer S., Wei&#xdf;brich B., Snijder E.J., Rabenau H., Doerr H.W., et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 2003;84:2305&#x2013;2315. doi: 10.1099/vir.0.19424-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19424-0</ArticleId><ArticleId IdType="pubmed">12917450</ArticleId></ArticleIdList></Reference><Reference><Citation>Viehweger A., Krautwurst S., Lamkiewicz K., Madhugiri R., Ziebuhr J., H&#xf6;lzer M., Marz M. Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis. Genome Res. 2019;29:1545&#x2013;1554. doi: 10.1101/gr.247064.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.247064.118</ArticleId><ArticleId IdType="pmc">PMC6724671</ArticleId><ArticleId IdType="pubmed">31439691</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasternak A.O., Spaan W.J., Snijder E.J. Regulation of relative abundance of arterivirus subgenomic mRNAs. J. Virol. 2004;78:8102&#x2013;8113. doi: 10.1128/JVI.78.15.8102-8113.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.8102-8113.2004</ArticleId><ArticleId IdType="pmc">PMC446141</ArticleId><ArticleId IdType="pubmed">15254182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sola I., Mateos-Gomez P.A., Almazan F., Zu&#xf1;iga S., Enjuanes L. RNA-RNA and RNA-protein interactions in coronavirus replication and transcription. RNA Biol. 2011;8:237&#x2013;248. doi: 10.4161/rna.8.2.14991.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.8.2.14991</ArticleId><ArticleId IdType="pmc">PMC3230552</ArticleId><ArticleId IdType="pubmed">21378501</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H.Y., Guan B.J., Su Y.P., Fan Y.H., Brian D.A. Reselection of a genomic upstream open reading frame in mouse hepatitis coronavirus 5&#x2032;-untranslated-region mutants. J. Virol. 2014;88:846&#x2013;858. doi: 10.1128/JVI.02831-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02831-13</ArticleId><ArticleId IdType="pmc">PMC3911626</ArticleId><ArticleId IdType="pubmed">24173235</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd A.K., Raney K.D. Superfamily 2 helicases. Front. Biosci. Landmark Ed. 2012;17:2070&#x2013;2088. doi: 10.2741/4038.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/4038</ArticleId><ArticleId IdType="pmc">PMC3775597</ArticleId><ArticleId IdType="pubmed">22652765</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmott E., Munday D., Bickerton E., Britton P., Rodgers M.A., Whitehouse A., Zhou E.M., Hiscox J.A. The cellular interactome of the coronavirus infectious bronchitis virus nucleocapsid protein and functional implications for virus biology. J. Virol. 2013;87:9486&#x2013;9500. doi: 10.1128/JVI.00321-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00321-13</ArticleId><ArticleId IdType="pmc">PMC3754094</ArticleId><ArticleId IdType="pubmed">23637410</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartier C., Sivard P., Tranchat C., Decimo D., Desgranges C., Boyer V. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection. J. Biol. Chem. 1999;274:19434&#x2013;19440. doi: 10.1074/jbc.274.27.19434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.27.19434</ArticleId><ArticleId IdType="pubmed">10383459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov K.I., Puustinen P., Gabrenaite R., Vihinen H., R&#xf6;nnstrand L., Valmu L., Kalkkinen N., M&#xe4;kinen K. Phosphorylation of the potyvirus capsid protein by protein kinase CK2 and its relevance for virus infection. Plant Cell. 2003;15:2124&#x2013;2139. doi: 10.1105/tpc.012567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1105/tpc.012567</ArticleId><ArticleId IdType="pmc">PMC181335</ArticleId><ArticleId IdType="pubmed">12953115</ArticleId></ArticleIdList></Reference><Reference><Citation>Law L.M., Everitt J.C., Beatch M.D., Holmes C.F., Hobman T.C. Phosphorylation of rubella virus capsid regulates its RNA binding activity and virus replication. J. Virol. 2003;77:1764&#x2013;1771. doi: 10.1128/JVI.77.3.1764-1771.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.3.1764-1771.2003</ArticleId><ArticleId IdType="pmc">PMC140988</ArticleId><ArticleId IdType="pubmed">12525610</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Lei X., Jiang Z., Humphries F., Parsi K.M., Mustone N.J., Ramos I., Mutetwa T., Fernandez-Sesma A., Maehr R., et al. Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates. Proc. Natl. Acad. Sci. USA. 2023;120:e2308355120. doi: 10.1073/pnas.2308355120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2308355120</ArticleId><ArticleId IdType="pmc">PMC10666094</ArticleId><ArticleId IdType="pubmed">37963251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Pan J., Tao J., Guo D. SARS-CoV nucleocapsid protein antagonizes IFN-&#x3b2; response by targeting initial step of IFN-&#x3b2; induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes. 2011;42:37&#x2013;45. doi: 10.1007/s11262-010-0544-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-010-0544-x</ArticleId><ArticleId IdType="pmc">PMC7088804</ArticleId><ArticleId IdType="pubmed">20976535</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Ma L., Cai S., Zhuang Z., Zhao Z., Jin S., Xie W., Zhou L., Zhang L., Zhao J., et al. RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-&#x3ba;B hyper-activation and inflammation. Signal Transduct. Target. Ther. 2021;6:167. doi: 10.1038/s41392-021-00575-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00575-7</ArticleId><ArticleId IdType="pmc">PMC8065320</ArticleId><ArticleId IdType="pubmed">33895773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai F.W., Stephenson K.B., Mahony J., Lichty B.D. Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-&#x3ba;B activation. J. Virol. 2014;88:54&#x2013;65. doi: 10.1128/JVI.02678-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02678-13</ArticleId><ArticleId IdType="pmc">PMC3911702</ArticleId><ArticleId IdType="pubmed">24109243</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan L.X., Liang J.Q., Zhu Q.C., Dai G., Li S., Fung T.S., Liu D.X. Gammacoronavirus Avian Infectious Bronchitis Virus and Alphacoronavirus Porcine Epidemic Diarrhea Virus Exploit a Cell-Survival Strategy via Upregulation of cFOS to Promote Viral Replication. J. Virol. 2021;95:e02107-20. doi: 10.1128/JVI.02107-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02107-20</ArticleId><ArticleId IdType="pmc">PMC7851560</ArticleId><ArticleId IdType="pubmed">33239458</ArticleId></ArticleIdList></Reference><Reference><Citation>Patarca R., Haseltine W.A. Intragenomic rearrangements involving 5&#x2032;-untranslated region segments in SARS-CoV-2, other betacoronaviruses, and alphacoronaviruses. Virol. J. 2023;20:36. doi: 10.1186/s12985-023-01998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-01998-0</ArticleId><ArticleId IdType="pmc">PMC9957694</ArticleId><ArticleId IdType="pubmed">36829234</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne L.G., Bouhaddou M., Reuschl A.K., Zuliani-Alvarez L., Polacco B., Pelin A., Batra J., Whelan M.V.X., Hosmillo M., Fossati A., et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2022;602:487&#x2013;495. doi: 10.1038/s41586-021-04352-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04352-y</ArticleId><ArticleId IdType="pmc">PMC8850198</ArticleId><ArticleId IdType="pubmed">34942634</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuschl A.K., Thorne L.G., Whelan M.V.X., Ragazzini R., Furnon W., Cowton V.M., De Lorenzo G., Mesner D., Turner J.L.E., Dowgier G., et al. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants. Nat. Microbiol. 2024 doi: 10.1038/s41564-023-01588-4. advance online publication .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-023-01588-4</ArticleId><ArticleId IdType="pmc">PMC10847042</ArticleId><ArticleId IdType="pubmed">38228858</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerman M., Guyader M., Montagnier L., Baltimore D., Muesing M.A. The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J. 1987;6:3755&#x2013;3760. doi: 10.1002/j.1460-2075.1987.tb02710.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1987.tb02710.x</ArticleId><ArticleId IdType="pmc">PMC553846</ArticleId><ArticleId IdType="pubmed">2828036</ArticleId></ArticleIdList></Reference><Reference><Citation>Selby M.J., Bain E.S., Luciw P.A., Peterlin B.M. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 1989;3:547&#x2013;558. doi: 10.1101/gad.3.4.547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.3.4.547</ArticleId><ArticleId IdType="pubmed">2470647</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Mart&#xed;nez L.F., Mavankal G., Peters P., Wu-Baer F., Gaynor R.B. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2. J. Mol. Biol. 1995;254:350&#x2013;363. doi: 10.1006/jmbi.1995.0622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1995.0622</ArticleId><ArticleId IdType="pubmed">7490754</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeang K.T., Chun R., Lin N.H., Gatignol A., Glabe C.G., Fan H. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 1993;67:6224&#x2013;6233. doi: 10.1128/jvi.67.10.6224-6233.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.10.6224-6233.1993</ArticleId><ArticleId IdType="pmc">PMC238044</ArticleId><ArticleId IdType="pubmed">7690421</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun R.F., Semmes O.J., Neuveut C., Jeang K.T. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 1998;72:2615&#x2013;2629. doi: 10.1128/JVI.72.4.2615-2629.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.4.2615-2629.1998</ArticleId><ArticleId IdType="pmc">PMC109697</ArticleId><ArticleId IdType="pubmed">9525578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Liu J., Wang Q., Liu X., Li X., Li P., Ma Q., Cao C. The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha. J. Virol. 2008;82:6962&#x2013;6971. doi: 10.1128/JVI.00133-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00133-08</ArticleId><ArticleId IdType="pmc">PMC2446950</ArticleId><ArticleId IdType="pubmed">18448518</ArticleId></ArticleIdList></Reference><Reference><Citation>Subissi L., Posthuma C.C., Collet A., Zevenhoven-Dobbe J.C., Gorbalenya A.E., Decroly E., Snijder E.J., Canard B., Imbert I. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc. Natl. Acad. Sci. USA. 2014;111:E3900&#x2013;E3909. doi: 10.1073/pnas.1323705111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1323705111</ArticleId><ArticleId IdType="pmc">PMC4169972</ArticleId><ArticleId IdType="pubmed">25197083</ArticleId></ArticleIdList></Reference><Reference><Citation>El Baba R., Herbein G. Management of epigenomic networks entailed in coronavirus infections and COVID-19. Clin. Epigenet. 2020;12:118. doi: 10.1186/s13148-020-00912-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-00912-7</ArticleId><ArticleId IdType="pmc">PMC7404079</ArticleId><ArticleId IdType="pubmed">32758273</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaborowska J., Isa N.F., Murphy S. P-TEFb goes viral. BioEssays News Rev. Mol. Cell. Dev. Biol. 2016;38((Suppl. S1)):S75&#x2013;S85. doi: 10.1002/bies.201670912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201670912</ArticleId><ArticleId IdType="pubmed">27417125</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Mu&#xf1;oz A.D., Santos J.J.S., Yewdell J.W. Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy. Proc. Natl. Acad. Sci. USA. 2023;120:e2304087120. doi: 10.1073/pnas.2304087120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2304087120</ArticleId><ArticleId IdType="pmc">PMC10334784</ArticleId><ArticleId IdType="pubmed">37399385</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanaga K., Yamanouchi K., Fujiwara K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J. Virol. 1986;59:168&#x2013;171. doi: 10.1128/jvi.59.1.168-171.1986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.59.1.168-171.1986</ArticleId><ArticleId IdType="pmc">PMC253053</ArticleId><ArticleId IdType="pubmed">3012115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecomte J., Cainelli-Gebara V., Mercier G., Mansour S., Talbot P.J., Lussier G., Oth D. Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Brief report. Arch. Virol. 1987;97:123&#x2013;130. doi: 10.1007/BF01310740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01310740</ArticleId><ArticleId IdType="pmc">PMC7086664</ArticleId><ArticleId IdType="pubmed">2825619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparn C., Meyer A., Saleppico R., Nickel W. Unconventional secretion mediated by direct protein self-translocation across the plasma membranes of mammalian cells. Trends Biochem. Sci. 2022;47:699&#x2013;709. doi: 10.1016/j.tibs.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2022.04.001</ArticleId><ArticleId IdType="pubmed">35490075</ArticleId></ArticleIdList></Reference><Reference><Citation>Fittipaldi A., Giacca M. Transcellular protein transduction using the Tat protein of HIV-1. Adv. Drug Deliv. Rev. 2005;57:597&#x2013;608. doi: 10.1016/j.addr.2004.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2004.10.011</ArticleId><ArticleId IdType="pubmed">15722166</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi M., Rusnati M., Presta M., Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 2001;276:3254&#x2013;3261. doi: 10.1074/jbc.M006701200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M006701200</ArticleId><ArticleId IdType="pubmed">11024024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz A.P., Ajasin D.O., Ramasamy S., DesMarais V., Eugenin E.A., Prasad V.R. A naturally occurring polymorphism in the HIV-1 tat basic domain inhibits uptake by bystander cells and leads to reduced neuroinflammation. Sci. Rep. 2019;9:3308. doi: 10.1038/s41598-019-39531-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39531-5</ArticleId><ArticleId IdType="pmc">PMC6397180</ArticleId><ArticleId IdType="pubmed">30824746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajasin D., Eugenin E.A. HIV-1 Tat: Role in bystander toxicity. Front. Cell. Infect. Microbiol. 2020;10:61. doi: 10.3389/fcimb.2020.00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00061</ArticleId><ArticleId IdType="pmc">PMC7052126</ArticleId><ArticleId IdType="pubmed">32158701</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadhav S., Nema V. HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins. Mediators Inflamm. 2021;2021:1267041. doi: 10.1155/2021/1267041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/1267041</ArticleId><ArticleId IdType="pmc">PMC8410439</ArticleId><ArticleId IdType="pubmed">34483726</ArticleId></ArticleIdList></Reference><Reference><Citation>Buscemi L., Ramonet D., Geiger J.D. Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor- &#x3b1;-mediated neurotoxicity. Neurobiol. Dis. 2007;26:661&#x2013;670. doi: 10.1016/j.nbd.2007.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.03.004</ArticleId><ArticleId IdType="pmc">PMC2080622</ArticleId><ArticleId IdType="pubmed">17451964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul M., Zheng J., Okamoto S., Gendelman H.E., Lipton S.A. HIV-1 infection and AIDS: Consequences for the central nervous system. Cell Death Differ. 2005;12:878&#x2013;892. doi: 10.1038/sj.cdd.4401623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401623</ArticleId><ArticleId IdType="pubmed">15832177</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedwin G.E., Naylor S.L., Sakaguchi A.Y., Smith D., Jarrett-Nedwin J., Pennica D., Goeddel D.V., Gray P.W. Human lymphotoxin and tumor necrosis factor genes: Structure, homology and chromosomal localization. Nucleic Acids Res. 1985;13:6361&#x2013;6373. doi: 10.1093/nar/13.17.6361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/13.17.6361</ArticleId><ArticleId IdType="pmc">PMC321958</ArticleId><ArticleId IdType="pubmed">2995927</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K.P., Vunnam S.R., Patel P.A., Krill K.L., Korbitz P.M., Gallagher J.P., Suh J.E., Vunnam R.R. Transmission of SARS-CoV-2: An update of current literature. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:2005&#x2013;2011. doi: 10.1007/s10096-020-03961-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-03961-1</ArticleId><ArticleId IdType="pmc">PMC7339796</ArticleId><ArticleId IdType="pubmed">32638221</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo C., Kaushal S., Yeo D. Enteric involvement of coronaviruses: Is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 2020;5:335&#x2013;337. doi: 10.1016/S2468-1253(20)30048-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30048-0</ArticleId><ArticleId IdType="pmc">PMC7130008</ArticleId><ArticleId IdType="pubmed">32087098</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalonm P., Kohn L., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R., Shunmugam L., Naidoo K., Abdool Karim S.S., Wilkins D., Garzino-Demo A., Brechot C., Parthasarathy S., Vahlne A., Nikolich J.&#x17d;. Long COVID: A review and proposed visualization of the complexity of long COVID. Front. Immunol. 2023;14:1117464. doi: 10.3389/fimmu.2023.1117464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Martino L., Morello R., Mariani F., Fearnley K., Valentini P. Viral persistence in children infected with SARS-CoV-2: Current evidence and future research strategies. Lancet Microbe. 2023;4:e745&#x2013;e756. doi: 10.1016/S2666-5247(23)00115-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00115-5</ArticleId><ArticleId IdType="pmc">PMC10292824</ArticleId><ArticleId IdType="pubmed">37385286</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupelli L.A., Hsu M.C. The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter. J. Virol. 1995;69:2640&#x2013;2643. doi: 10.1128/jvi.69.4.2640-2643.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.4.2640-2643.1995</ArticleId><ArticleId IdType="pmc">PMC188946</ArticleId><ArticleId IdType="pubmed">7884917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang S., Tamilarasu N., Kibler K., Cao H., Ali A., Ping Y.H., Jeang K.T., Rana T.M. Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication. J. Biol. Chem. 2003;278:39092&#x2013;39103. doi: 10.1074/jbc.M301749200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301749200</ArticleId><ArticleId IdType="pubmed">12857725</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis B., Afshar M., Varani G., Murchie A.I., Karn J., Lentzen G., Drysdale M., Bower J., Potter A.J., Starkey I.D., et al. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic &#x201c;hot spots&#x201d;. J. Mol. Biol. 2004;336:343&#x2013;356. doi: 10.1016/j.jmb.2003.12.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2003.12.046</ArticleId><ArticleId IdType="pubmed">14757049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu M.C., Schutt A.D., Holly M., Slice L.W., Sherman M.I., Richman D.D., Potash M.J., Volsky D.J. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science. 1991;254:1799&#x2013;1802. doi: 10.1126/science.1763331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1763331</ArticleId><ArticleId IdType="pubmed">1763331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.I., Kim G.N., Yu K.L., Park S.H., You J.C. Identification of Novel Nucleocapsid Chimeric Proteins Inhibiting HIV-1 Replication. Int. J. Mol. Sci. 2022;23:12340. doi: 10.3390/ijms232012340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232012340</ArticleId><ArticleId IdType="pmc">PMC9604505</ArticleId><ArticleId IdType="pubmed">36293198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Ammar A., Kula A., Darcis G., Verdikt R., De Wit S., Gautier V., Mallon P.W.G., Marcello A., Rohr O., Van Lint C. Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. Front. Microbiol. 2020;10:3060. doi: 10.3389/fmicb.2019.03060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.03060</ArticleId><ArticleId IdType="pmc">PMC6993040</ArticleId><ArticleId IdType="pubmed">32038533</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson M., Zaretskaya I., Raytselis Y., Merezhuk Y., McGinnis S., Madden T.L. NCBI BLAST: A better web interface. Nucleic Acids Res. 2008;36:W5&#x2013;W9. doi: 10.1093/nar/gkn201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn201</ArticleId><ArticleId IdType="pmc">PMC2447716</ArticleId><ArticleId IdType="pubmed">18440982</ArticleId></ArticleIdList></Reference><Reference><Citation>ICTV Coronaviridae Study Group  International Committee on Taxonomy of Viruses (ICTV) 2021.  [(accessed on 25 September 2023)].  Available online:  https://talk.ictvonline.org/ictv-reports/ictv_9th_report/positive-sense-rna-viruses-2011/w/posrna_viruses/223/coronaviridae-figures.</Citation></Reference><Reference><Citation>Nikolaidis M., Markoulatos P., van de Peer Y., Oliver S.G., Amoutzias G.D. The neighborhood of the spike gene is a hotspot for modular intertypic homologous and non-homologous recombination in coronavirus genomes. Mol. Biol. Evol. 2022;39:msab292. doi: 10.1093/molbev/msab292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msab292</ArticleId><ArticleId IdType="pmc">PMC8549283</ArticleId><ArticleId IdType="pubmed">34638137</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoleridis T., Chappell J.G., Onianwa O., Marston D.A., Fooks A.R., Monchatre-Leroy E., Umhang G., M&#xfc;ller M.A., Drexler J.F., Drosten C., et al. Shared Common Ancestry of Rodent Alphacoronaviruses Sampled Globally. Viruses. 2019;11:125. doi: 10.3390/v11020125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11020125</ArticleId><ArticleId IdType="pmc">PMC6409636</ArticleId><ArticleId IdType="pubmed">30704076</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeira F., Pearce M., Tivey A.R.N., Basutkar P., Lee J., Edbali O., Madhusoodanan N., Kolesnikov A., Lopez R. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res. 2022;50:W276&#x2013;W279. doi: 10.1093/nar/gkac240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac240</ArticleId><ArticleId IdType="pmc">PMC9252731</ArticleId><ArticleId IdType="pubmed">35412617</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerpedjiev P., Hammer S., Hofacker I.L. Forna (force-directed RNA): Simple and effective online RNA secondary structure diagrams. Bioinformatics. 2015;31:3377&#x2013;3379. doi: 10.1093/bioinformatics/btv372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv372</ArticleId><ArticleId IdType="pmc">PMC4595900</ArticleId><ArticleId IdType="pubmed">26099263</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber A.R., Lorenz R., Bernhart S.H., Neub&#xf6;ck R., Hofacker I.L. The Vienna RNA Websuite. Nucleic Acids Res. 2008;36:W70&#x2013;W74. doi: 10.1093/nar/gkn188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn188</ArticleId><ArticleId IdType="pmc">PMC2447809</ArticleId><ArticleId IdType="pubmed">18424795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz R., Bernhart S.H., H&#xf6;ner zu Siederdissen C., Tafer H., Flamm C., Stadler P.F., Hofacker I.L. ViennaRNA Package 2.0. Algorithms Mol. Biol. 2011;6:26. doi: 10.1186/1748-7188-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-7188-6-26</ArticleId><ArticleId IdType="pmc">PMC3319429</ArticleId><ArticleId IdType="pubmed">22115189</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul S.F., Madden T.L., Sch&#xe4;ffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389&#x2013;3402. doi: 10.1093/nar/25.17.3389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/25.17.3389</ArticleId><ArticleId IdType="pmc">PMC146917</ArticleId><ArticleId IdType="pubmed">9254694</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>